BioSpace News Archive

BIO 300 will be tested as a post-infection prophylactic to mitigate pulmonary inflammation leading to COVID-19 complications

CENTEGIX’s contact tracing solution ContactAlert™ qualifies for federal funding from the stimulus package passed by the U.S. Congress in December 2020.

American Bio Medica Corporation, a US-based manufacturer of accurate, cost-effective immunoassay test kits, issued a statement regarding President Joe Biden’s executive order directing the federal government to increase its purchases of goods Made in America.

A medical-technology executive and a former state legislator have been named the new leaders of Arizona’s statewide committee overseeing the advancement of the state’s bioscience ecosystem.

In an effort to provide clear, useful, authoritative information to rare disease patients and caregivers on the COVID-19 vaccines, on January 15 the National Organization for Rare Disorders, along with The ALS Association, Cystic Fibrosis Foundation and Muscular Dystrophy Association, hosted a special webinar with leaders from the US Food and Drug Administration and the Centers for Disease Control and Prevention.

Inspired Spine has announced the Trident SI Joint Screw System, manufactured by Advanced Research Medical (ARM), has secured FDA 510(k) marketing clearance.

WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to identify precancerous and cancerous cells in the esophagus, is now considered a medically necessary service by BlueCross BlueShield of South Carolina.

Exogenesis nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today the completion of production validation and sterilization validation as an immediate prelude to commercialization of Exogenesis nanoMesh™.

New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization

Catalyst Biosciences, Inc., announced that it is offering shares of its common stock in an underwritten public offering.